Methodological considerations for measuring rates of brain atrophy

Jeffrey L. Gunter, Maria M. Shiung, Armando Manduca, Clifford R Jr. Jack

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Purpose: To systematically compare two techniques for measuring brain atrophy rates from serial magnetic resonance imaging (MRI) studies. Materials and Methods: Using the separation in atrophy rate between cohorts of cognitively normal elderly subjects and patients with Alzheimer's disease (AD) as the gold standard we evaluated 1) different methods of computing volume change; 2) different methods for steps in image preprocessing - intensity normalization, alignment mask used, and bias field correction; 3) the effect of MRI acquisition hardware changes; and 4) the sensitivity of the method to variations in initial manual volume editing. For each of the preceding evaluations, measurements of whole-brain and ventricular atrophy rates were calculated. Results: In general, greater separation between the clinical groups was seen with ventricular rather than whole-brain measures. Surprisingly, neither the use of bias field correction nor a major hardware change between the scan pairs affected group separation. Conclusion: Atrophy rate measurements from serial MRI are candidates for use as surrogate markers of disease progression in AD and other dementing neurodegenerative disorders. The final method has excellent precision and accurately captures the expected biology of AD - arguably the two most important features if this technique is to be used as a biomarker of disease progression.

Original languageEnglish (US)
Pages (from-to)16-24
Number of pages9
JournalJournal of Magnetic Resonance Imaging
Volume18
Issue number1
DOIs
StatePublished - Jul 1 2003

Fingerprint

Atrophy
Brain
Alzheimer Disease
Magnetic Resonance Imaging
Disease Progression
Biomarkers
Masks
Neurodegenerative Diseases

Keywords

  • Alzheimer's disease
  • Brain atrophy
  • Dementia
  • Image processing
  • Serial MRI

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Methodological considerations for measuring rates of brain atrophy. / Gunter, Jeffrey L.; Shiung, Maria M.; Manduca, Armando; Jack, Clifford R Jr.

In: Journal of Magnetic Resonance Imaging, Vol. 18, No. 1, 01.07.2003, p. 16-24.

Research output: Contribution to journalArticle

@article{73ecd4b030f6498e93cfda8f009f68bd,
title = "Methodological considerations for measuring rates of brain atrophy",
abstract = "Purpose: To systematically compare two techniques for measuring brain atrophy rates from serial magnetic resonance imaging (MRI) studies. Materials and Methods: Using the separation in atrophy rate between cohorts of cognitively normal elderly subjects and patients with Alzheimer's disease (AD) as the gold standard we evaluated 1) different methods of computing volume change; 2) different methods for steps in image preprocessing - intensity normalization, alignment mask used, and bias field correction; 3) the effect of MRI acquisition hardware changes; and 4) the sensitivity of the method to variations in initial manual volume editing. For each of the preceding evaluations, measurements of whole-brain and ventricular atrophy rates were calculated. Results: In general, greater separation between the clinical groups was seen with ventricular rather than whole-brain measures. Surprisingly, neither the use of bias field correction nor a major hardware change between the scan pairs affected group separation. Conclusion: Atrophy rate measurements from serial MRI are candidates for use as surrogate markers of disease progression in AD and other dementing neurodegenerative disorders. The final method has excellent precision and accurately captures the expected biology of AD - arguably the two most important features if this technique is to be used as a biomarker of disease progression.",
keywords = "Alzheimer's disease, Brain atrophy, Dementia, Image processing, Serial MRI",
author = "Gunter, {Jeffrey L.} and Shiung, {Maria M.} and Armando Manduca and Jack, {Clifford R Jr.}",
year = "2003",
month = "7",
day = "1",
doi = "10.1002/jmri.10325",
language = "English (US)",
volume = "18",
pages = "16--24",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Methodological considerations for measuring rates of brain atrophy

AU - Gunter, Jeffrey L.

AU - Shiung, Maria M.

AU - Manduca, Armando

AU - Jack, Clifford R Jr.

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Purpose: To systematically compare two techniques for measuring brain atrophy rates from serial magnetic resonance imaging (MRI) studies. Materials and Methods: Using the separation in atrophy rate between cohorts of cognitively normal elderly subjects and patients with Alzheimer's disease (AD) as the gold standard we evaluated 1) different methods of computing volume change; 2) different methods for steps in image preprocessing - intensity normalization, alignment mask used, and bias field correction; 3) the effect of MRI acquisition hardware changes; and 4) the sensitivity of the method to variations in initial manual volume editing. For each of the preceding evaluations, measurements of whole-brain and ventricular atrophy rates were calculated. Results: In general, greater separation between the clinical groups was seen with ventricular rather than whole-brain measures. Surprisingly, neither the use of bias field correction nor a major hardware change between the scan pairs affected group separation. Conclusion: Atrophy rate measurements from serial MRI are candidates for use as surrogate markers of disease progression in AD and other dementing neurodegenerative disorders. The final method has excellent precision and accurately captures the expected biology of AD - arguably the two most important features if this technique is to be used as a biomarker of disease progression.

AB - Purpose: To systematically compare two techniques for measuring brain atrophy rates from serial magnetic resonance imaging (MRI) studies. Materials and Methods: Using the separation in atrophy rate between cohorts of cognitively normal elderly subjects and patients with Alzheimer's disease (AD) as the gold standard we evaluated 1) different methods of computing volume change; 2) different methods for steps in image preprocessing - intensity normalization, alignment mask used, and bias field correction; 3) the effect of MRI acquisition hardware changes; and 4) the sensitivity of the method to variations in initial manual volume editing. For each of the preceding evaluations, measurements of whole-brain and ventricular atrophy rates were calculated. Results: In general, greater separation between the clinical groups was seen with ventricular rather than whole-brain measures. Surprisingly, neither the use of bias field correction nor a major hardware change between the scan pairs affected group separation. Conclusion: Atrophy rate measurements from serial MRI are candidates for use as surrogate markers of disease progression in AD and other dementing neurodegenerative disorders. The final method has excellent precision and accurately captures the expected biology of AD - arguably the two most important features if this technique is to be used as a biomarker of disease progression.

KW - Alzheimer's disease

KW - Brain atrophy

KW - Dementia

KW - Image processing

KW - Serial MRI

UR - http://www.scopus.com/inward/record.url?scp=0038449893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038449893&partnerID=8YFLogxK

U2 - 10.1002/jmri.10325

DO - 10.1002/jmri.10325

M3 - Article

VL - 18

SP - 16

EP - 24

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 1

ER -